Dialyvite 3000 — Hillestad Pharmaceuticals USA drug label update
Hillestad Pharmaceuticals USA has updated the drug label for Dialyvite 3000, a prescription folic acid supplement intended for improving the nutritional status of patients undergoing renal dialysis.
This update affects Hillestad Pharmaceuticals USA, healthcare providers treating renal dialysis patients, and regulatory affairs professionals responsible for vitamin and supplement labeling within the prescription drug category.
The clarification of 'Indications and Usage' specifically for renal dialysis patients suggests a refined regulatory focus on ensuring the dosage and nutrient profile are correctly positioned for this vulnerable population. Regulatory teams should note the classification as a prescription supplement, which carries different compliance requirements compared to over-the-counter vitamins.
Regulatory and labeling teams should review the updated 'Indications and Usage' section to ensure internal product documentation and promotional materials align with the specific prescription status and renal dialysis focus. Verification of current inventory labels should be conducted to ensure compliance with the updated labeling.
Dialyvite 3000 (Hillestad Pharmaceuticals USA). INDICATIONS AND USAGE Dialyvite 3000 is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.
Open in openFDA / FDA.gov